NCT04062136

Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia

Outcomes of Human Umbilical Cord-derived Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology · Academic / Other
• Sex: All
• Age: 1 Month – 6 Months
• Healthy volunteers: Not accepted

Summary

To evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells transplantation in patients with bronchopulmonary dysplasia

Detailed description

The purpose of this study is to evaluate the safety and effectiveness of human umbilical cord mesenchymal stem cells in 10 patients with bronchopulmonary dysplasia at Vinmec International Hospital, Hanoi, Vietnam

Conditions

• Bronchopulmonary Dysplasia

Interventions

Type	Name	Description
COMBINATION_PRODUCT	stem cell transplantation	Transplantation of umbilical cord mesenchymal stem cells

Timeline

• Start date: 2019-03-01
• Primary completion: 2020-11-30
• Completion: 2020-11-30
• First posted: 2019-08-20
• Last updated: 2024-06-04

Locations

1 site across 1 country: Vietnam